{"abstract": "Novartis says it has reached an agreement with Alcon, the eye-care company, to buy the 23 percent of Alcon it does not already own.", "web_url": "https://dealbook.nytimes.com/2010/12/15/novartis-wraps-up-alcon-deal-for-12-9-billion/", "snippet": "Novartis says it has reached an agreement with Alcon, the eye-care company, to buy the 23 percent of Alcon it does not already own.", "lead_paragraph": "Novartis, the giant Swiss drug maker, said on Wednesday that it had reached an agreement with Alcon, the eye-care company, wrapping up a yearlong effort to buy the 23 percent of Alcon it does not already own. Novartis will use its stock to pay the equivalent of $168 for each Alcon share, valuing the transaction at $12.9 billion.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis Seals Alcon Deal for $12.9 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Alcon Incorporated", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 2, "major": "N"}], "pub_date": "2010-12-15T08:37:55+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Chris V. Nicholson", "person": [{"firstname": "Chris", "middlename": "V.", "lastname": "Nicholson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/ac5e8752-d188-51d4-9503-2b8262976a70", "word_count": 419, "uri": "nyt://article/ac5e8752-d188-51d4-9503-2b8262976a70"}